The report will be delivered in 2-3 business days.

Neutropenia Biologic Drug Treatment Global Market Report 2021 - By Drug Type (Filgrastim, Pegfilgrastim, Lenograstim, Lipegfilgrastim, Sargramostim), By Treatment Type (Antibiotic Drugs, Granulocyte-Colony-Stimulating Factor (G-CSF), Antifungal Drugs), By Distribution Channel (Retail Pharmacies, Hospital Pharmacies, Online Pharmacies), COVID-19 Growth And Change

aboutimg
Purchase Options
Request Sample
Request For Discount
FAQ
Infoimg

Starting Price : $5000.00 | Pages : 175 | Published : March 2021 | SKU CODE : 7728 | Format :


Description Table Of Contents Tables & Figures Market Insights Related Reports

The neutropenia biologic drug treatment market consists of sales of biologics used for the treatment of neutropenia and related services by entities (organizations, sole traders and partnerships) that produce biologics for neutropenia treatment. Neutropenia is a clinical condition characterized by a decrease in neutrophil count in the blood, resulting in a higher risk of developing serious infections. A neutrophil is a type of white blood cell, which helps in fighting infections. The major causes of neutropenia include cancer chemotherapy, infections, bone marrow disorders, autoimmune disorders, and the use of specific drugs. The market consists of revenue generated by the company’s manufacturing the neutropenia biologic drugs by the sales of these products.

The neutropenia biologic drug treatment market covered in this report is segmented by drug type into filgrastim, pegfilgrastim, lenograstim, lipegfilgrastim, sargramostim. The neutropenia biologic drug treatment market is also segmented by treatment type into antibiotic drugs, granulocyte-colony-stimulating factor (G-CSF), antifungal drugs, others and by distribution channel into retail pharmacies, hospital pharmacies, online pharmacies.

The global neutropenia biologic drug treatment market is expected to grow from $11.55 billion in 2020 to $12.19 billion in 2021 at a compound annual growth rate (CAGR) of 5.5%. The growth is mainly due to the companies resuming their operations and adapting to the new normal while recovering from the COVID-19 impact, which had earlier led to restrictive containment measures involving social distancing, remote working, and the closure of commercial activities that resulted in operational challenges. The neutropenia biologic drug treatment market is expected to reach $14.45 billion in 2025 at a CAGR of 4%.

The rise in the number of cancer cases across the globe is likely to contribute to the growth of the neutropenia biologic drugs market. Due to a growing cancer incidence and an increase in the number of people opting for chemotherapy, there has been an increasing incidence in the number of people suffering from neutropenia. According to a 2019 study by Cancer.net, around 50% of the people with cancer who are undergoing chemotherapy have some level of neutropenia. According to the American Cancer Society, there were 1.7 million new cases and 0.6 million cancer deaths in 2019 in the USA. Therefore, the rise in cancer incidence rate globally is anticipated to boost the demand for the neutropenia biologic drug treatment market over the forthcoming years.

 

The introduction of biosimilars as a result of patent expiry is expected to hamper the growth of the neutropenia biologic drug treatment market. Biosimilar is a therapeutic agent, which has high similarity with the original biological product in action but is available at a lower cost than the cost of the original product. Biosimilars are mostly priced at 70% of the branded drug price and are likely to replace expensive branded drugs. For instance, Novartis AG launched a biosimilar drug, Zarxio, which has substituted Amgen’s branded biologic drug, Neupogen. These less expensive alternatives increase competition in the biologics market putting downward pressure on pricing and market value growth.

 

Companies in the neutropenia biologic drug treatment market are increasingly investing in developing novel drug delivery systems to improve the therapeutic response of the drug and increase its efficacy. Novel drug delivery systems allow the delivery of a very high dose of drugs directly into the neutrophils, while the systemic dose remains low, thus disallowing side-effects. For instance, in August 2020, Asalyxa Bio announced its formation and seed funding to accelerate ASX-100 into first-in-human trials in 2021. ASX-100 is a novel spherical particle that releases a safe and effective anti-inflammatory agent, salicylic acid, directly to over-reactive immune cells, and is used for treating severe neutrophil-mediated disease.

 

In February 2018, Partner Therapeutics, a Boston-based cancer company, acquired Leukine (Sargramostim) from Sanofi for $60 million. Leukine is the only FDA-approved recombinant human granulocyte-macrophage colony-stimulating factor (GM-CSF) and it is indicated for the treatment of acute myelogenous leukemia (AML) in older adults both in allogeneic and autologous bone marrow transplantation. This acquisition provides a commercial business to Partner Therapeutics and also to make it a core component of the immune-oncology segment. Sanofi S.A. is a French multinational pharmaceutical company headquartered in Paris.

 

Major players in the neutropenia biologic drug treatment market neutropenia biologic drug treatment market are Teva Pharmaceutical, Amgen, Sanofi, Mylan, Kyowa Kirin, Baxter International, CVS Health Corp, Novartis, Spectrum Pharmaceuticals, and Partner Therapeutics.

The regions covered in the neutropenia biologic drug treatment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the neutropenia biologic drug treatment market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA.

The global neutropenia biologic drug treatment market is segmented -

1) By Drug Type: Filgrastim, Pegfilgrastim, Lenograstim, Lipegfilgrastim, Sargramostim

2) By Treatment Type: Antibiotic Drugs, Granulocyte-Colony-Stimulating Factor (G-CSF), Antifungal Drugs, Others

3) By Distribution Channel: Retail Pharmacies, Hospital Pharmacies, Online Pharmacies

    Table Of Contents

    1. Executive Summary

    2. Neutropenia Biologic Drug Treatment Market Characteristics

    3. Neutropenia Biologic Drug Treatment Market Trends And Strategies

    4. Impact Of COVID-19 On Neutropenia Biologic Drug Treatment

    5. Neutropenia Biologic Drug Treatment Market Size And Growth

    5.1. Global Neutropenia Biologic Drug Treatment Historic Market, 2015-2020, $ Billion

    5.1.1. Drivers Of The Market

    5.1.2. Restraints On The Market

    5.2. Global Neutropenia Biologic Drug Treatment Forecast Market, 2020-2025F, 2030F, $ Billion

    5.2.1. Drivers Of The Market

    5.2.2. Restraints On the Market

    6. Neutropenia Biologic Drug Treatment Market Segmentation

    6.1. Global Neutropenia Biologic Drug Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

    Filgrastim

    Pegfilgrastim

    Lenograstim

    Lipegfilgrastim

    Sargramostim

    6.2. Global Neutropenia Biologic Drug Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

    Antibiotic Drugs

    Granulocyte-Colony-Stimulating Factor (G-CSF)

    Antifungal Drugs

    Others

    6.3. Global Neutropenia Biologic Drug Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

    Retail Pharmacies

    Hospital Pharmacies

    Online Pharmacies

    7. Neutropenia Biologic Drug Treatment Market Regional And Country Analysis

    7.1. Global Neutropenia Biologic Drug Treatment Market, Split By Region, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

    7.2. Global Neutropenia Biologic Drug Treatment Market, Split By Country, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

    8. Asia-Pacific Neutropenia Biologic Drug Treatment Market

    8.1. Asia-Pacific Neutropenia Biologic Drug Treatment Market Overview

    Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

    8.2. Asia-Pacific Neutropenia Biologic Drug Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

    8.3. Asia-Pacific Neutropenia Biologic Drug Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

    9. China Neutropenia Biologic Drug Treatment Market

    9.1. China Neutropenia Biologic Drug Treatment Market Overview

    9.2. China Neutropenia Biologic Drug Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F,$ Billion

    9.3. China Neutropenia Biologic Drug Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F,$ Billion

    10. India Neutropenia Biologic Drug Treatment Market

    10.1. India Neutropenia Biologic Drug Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

    10.2. India Neutropenia Biologic Drug Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

    11. Japan Neutropenia Biologic Drug Treatment Market

    11.1. Japan Neutropenia Biologic Drug Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

    11.2. Japan Neutropenia Biologic Drug Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

    12. Australia Neutropenia Biologic Drug Treatment Market

    12.1. Australia Neutropenia Biologic Drug Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

    12.2. Australia Neutropenia Biologic Drug Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

    13. Indonesia Neutropenia Biologic Drug Treatment Market

    13.1. Indonesia Neutropenia Biologic Drug Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

    13.2. Indonesia Neutropenia Biologic Drug Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

    14. South Korea Neutropenia Biologic Drug Treatment Market

    14.1. South Korea Neutropenia Biologic Drug Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

    14.2. South Korea Neutropenia Biologic Drug Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

    15. Western Europe Neutropenia Biologic Drug Treatment Market

    15.1. Western Europe Neutropenia Biologic Drug Treatment Market Overview

    15.2. Western Europe Neutropenia Biologic Drug Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

    15.3. Western Europe Neutropenia Biologic Drug Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

    16. UK Neutropenia Biologic Drug Treatment Market

    16.1. UK Neutropenia Biologic Drug Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

    16.2. UK Neutropenia Biologic Drug Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

    17. Germany Neutropenia Biologic Drug Treatment Market

    17.1. Germany Neutropenia Biologic Drug Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

    17.2. Germany Neutropenia Biologic Drug Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

    18. France Neutropenia Biologic Drug Treatment Market

    18.4. France Neutropenia Biologic Drug Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

    18.5. France Neutropenia Biologic Drug Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

    19. Eastern Europe Neutropenia Biologic Drug Treatment Market

    19.1. Eastern Europe Neutropenia Biologic Drug Treatment Market Overview

    19.2. Eastern Europe Neutropenia Biologic Drug Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

    19.3. Eastern Europe Neutropenia Biologic Drug Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

    20. Russia Neutropenia Biologic Drug Treatment Market

    20.1. Russia Neutropenia Biologic Drug Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

    20.2. Russia Neutropenia Biologic Drug Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

    21. North America Neutropenia Biologic Drug Treatment Market

    21.1. North America Neutropenia Biologic Drug Treatment Market Overview

    21.2. North America Neutropenia Biologic Drug Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

    21.3. North America Neutropenia Biologic Drug Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

    22. USA Neutropenia Biologic Drug Treatment Market

    22.1. USA Neutropenia Biologic Drug Treatment Market Overview

    22.2. USA Neutropenia Biologic Drug Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

    22.3. USA Neutropenia Biologic Drug Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

    23. South America Neutropenia Biologic Drug Treatment Market

    23.1. South America Neutropenia Biologic Drug Treatment Market Overview

    23.2. South America Neutropenia Biologic Drug Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

    23.3. South America Neutropenia Biologic Drug Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

    24. Brazil Neutropenia Biologic Drug Treatment Market

    24.1. Brazil Neutropenia Biologic Drug Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

    24.2. Brazil Neutropenia Biologic Drug Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

    25. Middle East Neutropenia Biologic Drug Treatment Market

    25.1. Middle East Neutropenia Biologic Drug Treatment Market Overview

    25.2. Middle East Neutropenia Biologic Drug Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

    25.3. Middle East Neutropenia Biologic Drug Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

    26. Africa Neutropenia Biologic Drug Treatment Market

    26.1. Africa Neutropenia Biologic Drug Treatment Market Overview

    26.2. Africa Neutropenia Biologic Drug Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

    26.3. Africa Neutropenia Biologic Drug Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

    27. Neutropenia Biologic Drug Treatment Market Competitive Landscape And Company Profiles

    27.1. Neutropenia Biologic Drug Treatment Market Competitive Landscape

    27.2. Neutropenia Biologic Drug Treatment Market Company Profiles

    27.2.1. Teva Pharmaceutical

    27.2.1.1. Overview

    27.2.1.2. Products and Services

    27.2.1.3. Strategy

    27.2.1.4. Financial Performance

    27.2.2. Amgen

    27.2.2.1. Overview

    27.2.2.2. Products and Services

    27.2.2.3. Strategy

    27.2.2.4. Financial Performance

    27.2.3. Sanofi

    27.2.3.1. Overview

    27.2.3.2. Products and Services

    27.2.3.3. Strategy

    27.2.3.4. Financial Performance

    27.2.4. Mylan

    27.2.4.1. Overview

    27.2.4.2. Products and Services

    27.2.4.3. Strategy

    27.2.4.4. Financial Performance

    27.2.5. Kyowa Kirin

    27.2.5.1. Overview

    27.2.5.2. Products and Services

    27.2.5.3. Strategy

    27.2.5.4. Financial Performance

    28. Neutropenia Biologic Drug Treatment Pipeline Analysis

    29. Key Mergers And Acquisitions In The Neutropenia Biologic Drug Treatment Market

    30. Neutropenia Biologic Drug Treatment Market Future Outlook and Potential Analysis

    31. Appendix

    31.1. Abbreviations

    31.2. Currencies

    31.3. Research Inquiries

    31.4. The Business Research Company

    31.5. Copyright And Disclaimer

List Of Tables

    Table 1: Global Historic Market Growth, 2015-2020, $ Billion
  • Table 2: Global Forecast Market Growth, 2020-2025F, 2030F, $ Billion
  • Table 3: Global Neutropenia Biologic Drug Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Table 4: Global Neutropenia Biologic Drug Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Table 5: Global Neutropenia Biologic Drug Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Table 6: Global Neutropenia Biologic Drug Treatment Market, Split By Region, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Table 7: Global Neutropenia Biologic Drug Treatment Market, Split By Country, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Table 8: Asia-Pacific, Neutropenia Biologic Drug Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Table 9: Asia-Pacific, Neutropenia Biologic Drug Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Table 10: China, Neutropenia Biologic Drug Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Table 11: China, Neutropenia Biologic Drug Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Table 12: India, Neutropenia Biologic Drug Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Table 13: India, Neutropenia Biologic Drug Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Table 14: Japan, Neutropenia Biologic Drug Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Table 15: Japan, Neutropenia Biologic Drug Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Table 16: Australia, Neutropenia Biologic Drug Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Table 17: Australia, Neutropenia Biologic Drug Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Table 18: Indonesia, Neutropenia Biologic Drug Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Table 19: Indonesia, Neutropenia Biologic Drug Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Table 20: South Korea, Neutropenia Biologic Drug Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Table 21: South Korea, Neutropenia Biologic Drug Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Table 22: Western Europe, Neutropenia Biologic Drug Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Table 23: Western Europe, Neutropenia Biologic Drug Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Table 24: UK, Neutropenia Biologic Drug Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Table 25: UK, Neutropenia Biologic Drug Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Table 26: Germany, Neutropenia Biologic Drug Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Table 27: Germany, Neutropenia Biologic Drug Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Table 28: France, Neutropenia Biologic Drug Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Table 29: France, Neutropenia Biologic Drug Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Table 30: Eastern Europe, Neutropenia Biologic Drug Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Table 31: Eastern Europe, Neutropenia Biologic Drug Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Table 32: Russia, Neutropenia Biologic Drug Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Table 33: Russia, Neutropenia Biologic Drug Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Table 34: North America, Neutropenia Biologic Drug Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Table 35: North America, Neutropenia Biologic Drug Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Table 36: USA, Neutropenia Biologic Drug Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Table 37: USA, Neutropenia Biologic Drug Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Table 38: South America, Neutropenia Biologic Drug Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Table 39: South America, Neutropenia Biologic Drug Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Table 40: Brazil, Neutropenia Biologic Drug Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Table 41: Brazil, Neutropenia Biologic Drug Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Table 42: Middle East, Neutropenia Biologic Drug Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Table 43: Middle East, Neutropenia Biologic Drug Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Table 44: Africa, Neutropenia Biologic Drug Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Table 45: Africa, Neutropenia Biologic Drug Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Table 46: Teva Pharmaceutical Financial Performance
  • Table 47: Amgen Financial Performance
  • Table 48: Sanofi Financial Performance
  • Table 49: Mylan Financial Performance
  • Table 50: Kyowa Kirin Financial Performance

List Of Figures

    Figure 1: Global Historic Market Growth, 2015-2020, $ Billion
  • Figure 2: Global Forecast Market Growth, 2020-2025F, 2030F, $ Billion
  • Figure 3: Global Neutropenia Biologic Drug Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Figure 4: Global Neutropenia Biologic Drug Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Figure 5: Global Neutropenia Biologic Drug Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Figure 6: Global Neutropenia Biologic Drug Treatment Market, Split By Region, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Figure 7: Global Neutropenia Biologic Drug Treatment Market, Split By Country, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Figure 8: Asia-Pacific, Neutropenia Biologic Drug Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Figure 9: Asia-Pacific, Neutropenia Biologic Drug Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Figure 10: China, Neutropenia Biologic Drug Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Figure 11: China, Neutropenia Biologic Drug Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Figure 12: India, Neutropenia Biologic Drug Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Figure 13: India, Neutropenia Biologic Drug Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Figure 14: Japan, Neutropenia Biologic Drug Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Figure 15: Japan, Neutropenia Biologic Drug Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Figure 16: Australia, Neutropenia Biologic Drug Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Figure 17: Australia, Neutropenia Biologic Drug Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Figure 18: Indonesia, Neutropenia Biologic Drug Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Figure 19: Indonesia, Neutropenia Biologic Drug Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Figure 20: South Korea, Neutropenia Biologic Drug Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Figure 21: South Korea, Neutropenia Biologic Drug Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Figure 22: Western Europe, Neutropenia Biologic Drug Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Figure 23: Western Europe, Neutropenia Biologic Drug Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Figure 24: UK, Neutropenia Biologic Drug Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Figure 25: UK, Neutropenia Biologic Drug Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Figure 26: Germany, Neutropenia Biologic Drug Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Figure 27: Germany, Neutropenia Biologic Drug Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Figure 28: France, Neutropenia Biologic Drug Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Figure 29: France, Neutropenia Biologic Drug Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Figure 30: Eastern Europe, Neutropenia Biologic Drug Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Figure 31: Eastern Europe, Neutropenia Biologic Drug Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Figure 32: Russia, Neutropenia Biologic Drug Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Figure 33: Russia, Neutropenia Biologic Drug Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Figure 34: North America, Neutropenia Biologic Drug Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Figure 35: North America, Neutropenia Biologic Drug Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Figure 36: USA, Neutropenia Biologic Drug Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Figure 37: USA, Neutropenia Biologic Drug Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Figure 38: South America, Neutropenia Biologic Drug Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Figure 39: South America, Neutropenia Biologic Drug Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Figure 40: Brazil, Neutropenia Biologic Drug Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Figure 41: Brazil, Neutropenia Biologic Drug Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Figure 42: Middle East, Neutropenia Biologic Drug Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Figure 43: Middle East, Neutropenia Biologic Drug Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Figure 44: Africa, Neutropenia Biologic Drug Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Figure 45: Africa, Neutropenia Biologic Drug Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Figure 46: Teva Pharmaceutical Financial Performance
  • Figure 47: Amgen Financial Performance
  • Figure 48: Sanofi Financial Performance
  • Figure 49: Mylan Financial Performance
  • Figure 50: Kyowa Kirin Financial Performance
Global Anti-Infective Drugs Market Report 2021 – Opportunities And Strategies, Market Forecast And Trends
Read More
Global Cell and Gene Therapy Market Report 2021 – Opportunities And Strategies, Market Forecast And Trends
Read More
Global Pharmaceutical Drugs And Biologics Logistics Market Report 2021 – Opportunities And Strategies, Market Forecast And Trends
Read More
Global Pharmaceutical Drugs Market Report 2021 – Opportunities And Strategies, Market Forecast And Trends
Read More
Global Microbiome Market Report 2021 – Opportunities And Strategies, Market Forecast And Trends
Read More
Global G-CSF (Granulocyte Colony Stimulating Factors) Market Report 2021 – Opportunities And Strategies, Market Forecast And Trends
Read More
Global Vascular Endothelial Growth Factor (VEGF) Inhibitor Market Report 2021 – Opportunities And Strategies, Market Forecast And Trends
Read More
Global Therapeutic Proteins Market Report 2021 – Opportunities And Strategies, Market Forecast And Trends
Read More
Wearable Blood Pressure Monitors Market - By Product (Upper Arm Blood Pressure Monitor, Wrist Blood Pressure Monitor, Finger Blood Pressure Monitor), And By Region, Opportunities And Strategies - Global Forecast To 2030
View Report
Stem Cell/Cord Blood Banking Global Market Report 2021 - By Cell Type (Adult Stem Cells, Umbilical Cord Blood Stem Cells, Embryonic Stem Cells), By Service (Collection, Processing, Analysis, Storage), By Bank Type: Public, Private), By Application (Leukemia, Anemia, Thalassemia, Autism, Cerebral Palsy, Diabetes), COVID-19 Growth And Change
View Report
Blood Transfusion Diagnostics Global Market Report 2021 - By Type (Instruments and Kits, Reagents), By End User (Hospitals, Diagnostic Laboratories, Blood Banks, Plasma Fractionation Companies), By Technology (Western Blot, ELISA, Nucleic Acid Amplification, Fluorescence Assay, Rapid Test), By Application (Blood Grouping, Disease Screening), COVID-19 Growth And Change
View Report
Patient Blood Management Global Market Report 2021 - By Product (Instruments, Accessories, Reagents And Kits, Softwares), By Component (Plasma, Whole Blood, Red Blood Cells), By Application (Hospital, Clinic), COVID-19 Growth And Change
View Report
Wearable Blood Pressure Monitors Global Market Report 2021 - By Product (Wrist Blood Pressure Monitor, Upper Arm Blood Pressure Monitor, Finger Blood Pressure Monitor), By Technology (Wi-Fi Based, Bluetooth Based), By Application (Hospital, Clinic, Home Care Settings), COVID-19 Growth And Change
View Report
Blood Glucose Meters Global Market Report 2021 - By Product Type (Electrode Type Blood Glucose Meter, Photoelectric Blood Glucose Meter), By End User (Hospitals, Home Care), By Application (Type 1 Diabetes, Type 2 Diabetes, Gestational Diabetes), COVID-19 Impact And Recovery
View Report
Anemia And Other Blood Disorder Drugs Global Market Report 2021 - By Type (Iron Deficiency Anemia, Chronic Kidney Disease Anemia, Sickle Cell Anemia, Aplastic Anemia), By Distribution Channel (Hospitals Pharmacy, Online Pharmacy, Pharmacy), By Route of Administration (Oral, Injectable), By Anemia Type (Microcytic (Low MCV), Normocytic (Normal MCV), Macrocytic (High MCV)), COVID-19 Impact And Recovery
View Report
Blood Cancer Drugs Global Market Report 2021 - By Blood Cancer Type (Leukemia, Lymphoma, Myeloma), By Drugs (Rituaxan/Mabthera (Rituximab), Gleevac/Glivec (Imatinib), Revlimid (Lenalidomide), Velcade (Bortezomib), Tasigna (Nilotinib), Pomalyst (Pomalidomide), Vidaza (Azacitidine), Kyprolis (Carfilzomib), Adcetris (Brentuximab Vedotin)), By Treatment Approaches (Key Findings, Chemotherapeutic, MAbs/Targeted Therapies, Immunotherapeutic), COVID-19 Impact And Recovery
View Report

Call Us

+1 3156230293

(Americas)

+44 2071930708

(Europe)

+91 8897263534

(Asia & Others)